Larvol Delta - Clinical-Trial-of-BP1001-Liposomal-Grb2-Antisense-Oligonucleotide-in-Combination-With-Dasatinib-in-Patients-With-Ph--CML-Who-Have-Failed-TKI-Ph-AML-Ph-MDS

BP001 (omalizumab biosimilar) - BiosanaPharma

dasatinib - Generic mfg.

prexigebersen (BP1001) - Bio-Path

http://clinicaltrials.gov/ct2/show/NCT02923986

May 28, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next